Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,058 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $276.03 | 5 | $0 (2024) |
| Novo Nordisk Inc | $186.81 | 10 | $0 (2024) |
| AbbVie Inc. | $55.97 | 3 | $0 (2021) |
| Amgen Inc. | $55.64 | 4 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.00 | 3 | $0 (2021) |
| Indivior Inc. | $41.38 | 3 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $39.41 | 3 | $0 (2021) |
| EISAI INC. | $38.63 | 2 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $37.07 | 3 | $0 (2022) |
| PFIZER INC. | $31.08 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.71 | 15 | AstraZeneca Pharmaceuticals LP ($250.02) |
| 2023 | $16.15 | 1 | PFIZER INC. ($16.15) |
| 2022 | $73.23 | 5 | EISAI INC. ($17.34) |
| 2021 | $492.70 | 34 | AbbVie Inc. ($55.97) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.17 | General |
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.22 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: Respiratory | ||||||
| 03/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 03/12/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Allergy/Immunology | ||||||
| 01/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/22/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/26/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardio-renal | ||||||
| 01/21/2022 | EISAI INC. | Aduhelm (Drug) | Food and Beverage | Cash or cash equivalent | $17.34 | General |
| Category: Neurology | ||||||
| 01/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: PRIMARY CARE | ||||||
| 01/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: RESPIRATORY | ||||||
| 01/07/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: OUD | ||||||
| 12/23/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Cardio-renal | ||||||
| 12/14/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 200 | 207 | $28,331 | $10,558 |
| 2022 | 7 | 207 | 306 | $28,900 | $9,958 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 78 | 78 | $15,288 | $4,378 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 64 | $8,114 | $3,255 | 40.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $2,684 | $1,582 | 59.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 18 | 18 | $1,620 | $729.90 | 45.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $625.00 | $612.50 | 98.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 93 | 93 | $19,623 | $6,157 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 37 | $5,328 | $2,098 | 39.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 24 | 26 | $2,340 | $1,055 | 45.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 14 | 28 | $921.00 | $454.16 | 49.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 17 | $544.00 | $156.94 | 28.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 13 | $52.00 | $28.63 | 55.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 16 | 92 | $92.00 | $9.11 | 9.9% |
About Christopher Roberson
Christopher Roberson is a Family healthcare provider based in Franklin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2021. The National Provider Identifier (NPI) number assigned to this provider is 1629650189.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Roberson has received a total of $1,058 in payments from pharmaceutical and medical device companies, with $475.71 received in 2024. These payments were reported across 55 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,058).
As a Medicare-enrolled provider, Roberson has provided services to 407 Medicare beneficiaries, totaling 513 services with total Medicare billing of $20,516. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Franklin, OH
- Active Since 04/24/2021
- Last Updated 04/24/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1629650189
Products in Payments
- AIRSUPRA (Drug) $250.02
- VRAYLAR (Drug) $55.97
- Ozempic (Drug) $51.55
- SUBLOCADE (Drug) $41.38
- BELSOMRA (Drug) $39.41
- Kerendia (Drug) $37.07
- TRINTELLIX (Drug) $32.57
- REXULTI (Drug) $29.86
- EVENITY (Biological) $27.21
- FARXIGA (Drug) $26.01
- XARELTO (Drug) $25.70
- GEMTESA (Drug) $23.72
- Livalo (Drug) $23.68
- ImmunoCAP (Device) $20.06
- XYOSTED (Drug) $17.98
- Aduhelm (Drug) $17.34
- VYVANSE (Drug) $16.43
- STIOLTO RESPIMAT (Drug) $16.38
- PAXLOVID (Drug) $16.15
- Repatha (Biological) $15.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Franklin
Dana Stallings, Np, NP
Family — Payments: $151,342
Ayme Rowland, Aprn, APRN
Family — Payments: $9,955
Dr. Patti Sparling, Fnp, FNP
Family — Payments: $9,256
Melissa Barber
Family — Payments: $8,126
Dr. Hannah Caplinger, Dnp, Pmhnp, Fnp-C, DNP, PMHNP, FNP-C
Family — Payments: $7,720
Caroline Morris
Family — Payments: $7,341